Ares Capital Corporation logo ARCC - Ares Capital Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 24
HOLD 8
SELL 0
STRONG
SELL
0
| PRICE TARGET: $19.00 DETAILS
HIGH: $19.00
LOW: $19.00
MEDIAN: $19.00
CONSENSUS: $19.00
DOWNSIDE: 0.21%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong
Trading 62.0% below fair value
Current Price $19.04
Bear Case $35.08 84.2% upside ($35.08 - $19.04) / $19.04 = 84.2% ROTCE 6.8% → 0.76x TBV
Fair Value $50.11 163.2% upside ($50.11 - $19.04) / $19.04 = 163.2% ROTCE 9.1% → 1.37x TBV
Bull Case $65.14 242.1% upside ($65.14 - $19.04) / $19.04 = 242.1% ROTCE 10.4% → 1.73x TBV

Adjust Assumptions

9.1%
7.7%

Key Value Driver

ROTCE (9.1%) vs. cost of equity (7.7%)

Implied Market Multiple 0.95x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $19.00 from 32 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $50.11 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $35.78 (44% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $19.00 (from 32 analysts). Our estimate is 234% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly